Abstract:BACKGROUND:Methyl-CpG-binding protein-2 (MeCP2) is a critical regulator for neural development. Either loss- or gain-of-function leads to severe neurodevelopmental disorders, such as Rett syndrome (RTT) and autism spectrum disorder (ASD). We set out to screen for MECP2 mutations in patients of ASD and determine whether these autism-related mutations may compromise the proper function of MeCP2.METHODS:Whole-exome sequencing was performed to screen MECP2 and other ASD candidate genes for 120 patients diagnosed with ASD. The parents of patients who were identified with MECP2 mutation were selected for further Sanger sequencing. Each patient accomplished the case report form including general information and clinical scales applied to assess their clinical features. Mouse cortical neurons and HEK-293 cells were cultured and transfected with MeCP2 wild-type (WT) or mutant to examine the function of autism-associated MeCP2 mutants. HEK-293 cells were used to examine the expression of MeCP2 mutant constructs with Western blot. Mouse cortical neurons were used to analyze neurites and axon outgrowth by immunofluorescence experiments.RESULTS:We identified three missense mutations of MECP2 from three autism patients by whole-exome sequencing: p.P152L (c.455C>T), p.P376S (c.1162C>T), and p.R294X (c.880C>T). Among these mutations, p.P152L and p.R294X were de novo mutations, whereas p.P376S was inherited maternally. The diagnosis of RTT was excluded in all three autism patients. Abnormalities of dendritic and axonal growth were found after autism-related MeCP2 mutants were expressed in mouse cortical neurons; suggesting that autism-related MECP2 mutations impair the proper development of neurons.CONCLUSIONS:Our study identified genetic mutations of the MECP2 gene in autism patients, which were previously considered to be associated primarily with RTT. This finding suggests that loss-of-function mutations of MECP2 may also lead to autism spectrum disorders.

Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs

Downregulation of CNPase in a MeCP2 Deficient Mouse Model of Rett Syndrome.

Selective Preservation of Cholinergic Mecp2 Rescues Specific Rett-Syndrome-Like Phenotypes in Mecp2(Stop) Mice

Genome-Wide Analysis Reveals Methyl-Cpg-Binding Protein 2-Dependent Regulation Of Micrornas In A Mouse Model Of Rett Syndrome

MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex.

MeCP2: Multifaceted Roles in Gene Regulation and Neural Development

Regulation of mRNA splicing by MeCP2 via epigenetic modifications in the brain

Identification of Autism-Related MECP2 Mutations by Whole-Exome Sequencing and Functional Validation

MeCP2 and neurodevelopmental disorders

MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

MicroRNA-197 controls ADAM10 expression to mediate MeCP2’s role in the differentiation of neuronal progenitors

MiR-130a Regulates Neurite Outgrowth and Dendritic Spine Density by Targeting MeCP2

MeCP2 links heterochromatin condensates and neurodevelopmental disease

Rett Syndrome-Causing Mutations Compromise MeCP2-mediated Liquid–liquid Phase Separation of Chromatin

Regulation Mechanism and Research Progress of MeCP2 in Rett Syndrome

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons

MECP2 duplication and mutations impair NSCs differentiation via miR-197 regulated ADAM10

Manipulations of MeCP2 in Glutamatergic Neurons Highlight Their Contributions to Rett and Other Neurological Disorders.

Mecp2 Regulates The Timing Of Critical Period Plasticity That Shapes Functional Connectivity In Primary Visual Cortex

A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels

Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus